Our Story
River Bioscience was established in 2004 as a sister company of Citrus Research International (CRI). The company is a fully owned commercial subsidiary of the Southern African Citrus Growers Association.
River Bioscience was the first company to produce, register, and launch a granulovirus product for commercial pest control of false codling moth (FCM). River Bioscience was also the first company to register and commercialise a bollworm nucleopolyhedrovirus in South Africa. We invest in innovation and thorough scientific research to ensure we play our part in the long-term sustainability of the agricultural sector.
Our Objectives
Innovative Products
To provide the Southern African Agricultural Industry with innovative products aimed at supporting long-term sustainability and improving its global competitiveness.
Commercialising Innovations
To commercialise innovations, developments, and discoveries arising from industry research.
Research Support
Profits are returned to the industry research and technical support structures under the direct control of the Citrus Growers Association of Southern Africa.
Expansion
Expansion of innovative plant protection products into both local and global markets.
Our Investment
River Bioscience has invested 100% shareholding in XSIT, a company based on the sterile insect technique (SIT). More than 20,000 hectares of citrus and grapes are under the SIT program for false codling moth control.
XSIT plays a significant role in the area-wide population suppression of False Codling Moth, which is regarded as a phytosanitary pest in important markets where our citrus is exported to. By River Bioscience investing in XSIT, we are assisting with contributing to the control of strategically important pests, as well as helping to drive the sustainability of our industry through supporting continued market access.
